JBTM Form 144 shows 30,000-share sale via Schwab on NYSE
Rhea-AI Filing Summary
JBTM has a Form 144 filing indicating an intended sale of 30,000 shares of common stock through The Charles Schwab Corporation on or after 11/26/2025 on the NYSE. The planned sale has an aggregate market value of $4,326,864, while 51,971,372 shares of the issuer’s stock are reported as outstanding. The seller acquired these 30,000 shares on 01/02/2025 in a stock merger transaction with the issuer. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about JBTM’s current or future operations.
Positive
- None.
Negative
- None.
FAQ
What does the JBTM Form 144 filing disclose?
The filing discloses that a JBTM affiliate plans to sell 30,000 shares of common stock under Rule 144, using The Charles Schwab Corporation as broker on the NYSE.
How many JBTM shares are planned to be sold and what is their value?
The filer reports an intention to sell 30,000 common shares of JBTM with an aggregate market value of $4,326,864.
How many JBTM shares are outstanding according to this Form 144?
The Form 144 states that 51,971,372 shares of JBTM’s stock are outstanding at the time of the filing.
When were the JBTM shares being sold under Form 144 originally acquired?
The 30,000 JBTM common shares were acquired on 01/02/2025 through a stock merger transaction with the issuer.
When is the JBTM Form 144 sale expected to occur?
The Form 144 lists an approximate date of sale of 11/26/2025 for the planned disposition of the 30,000 JBTM shares.
What representation does the seller make in the JBTM Form 144?
The seller represents that they do not know of any material adverse information about JBTM’s current or prospective operations that has not been publicly disclosed.